Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Waks AG"'
Autor:
Waks AG; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Martínez-Sáez O; Cancer Institute, Hospital Clinic of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain., Tarantino P; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Braso-Maristany F; Cancer Institute, Hospital Clinic of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Pascual T; Cancer Institute, Hospital Clinic of Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; SOLTI Cancer Research Group, Barcelona, Spain., Cortés J; International Breast Cancer Center (IBCC), Pangaea Oncology, Quironsalud Group, Barcelona, Spain.; IOB Madrid, Hospital Beata Maria Ana, Madrid, Spain.; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain., Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Prat A; Cancer Institute, Hospital Clinic of Barcelona, Barcelona, Spain. ALPRAT@clinic.cat.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. ALPRAT@clinic.cat.; Department of Medicine, University of Barcelona, Barcelona, Spain. ALPRAT@clinic.cat.; Breast Cancer Unit, IOB-QuirónSalud, Barcelona, Spain. ALPRAT@clinic.cat.; Reveal Genomics, Barcelona, Spain. ALPRAT@clinic.cat.
Publikováno v:
Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2024 Sep 13. Date of Electronic Publication: 2024 Sep 13.
Autor:
Park KU; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Lipsitz S; Harvard Medical School, Boston, Massachusetts, USA.; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts, USA., Dominici LS; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Lynce F; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Minami CA; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Nakhlis F; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Waks AG; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Warren LE; Harvard Medical School, Boston, Massachusetts, USA.; Radiation Oncology, Dana-Farber Brigham Cancer Center, Boston, Massachusetts, USA., Eidman N; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Frazier J; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hernandez L; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Leslie C; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rafte S; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Stroud D; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Weissman JS; Harvard Medical School, Boston, Massachusetts, USA.; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts, USA., King TA; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Mittendorf EA; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Cancer [Cancer] 2024 Aug 30. Date of Electronic Publication: 2024 Aug 30.
Autor:
Waks AG; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Chen EL; Brigham and Women's Hospital, Boston, MA., Graham N; Data Sciences, Dana-Farber Cancer Institute, Boston, MA., Frey AM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Almeida K; Pharmacy and Clinical Support, Dana-Farber Cancer Institute, Boston, MA., Attaya V; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Current Affiliation: Olema Oncology, San Francisco, CA., Ryding C; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Abbass I; Genentech, Inc, South San Francisco, CA., Fung A; Genentech, Inc, South San Francisco, CA., Sussell J; Genentech, Inc, South San Francisco, CA., Cortazar P; Genentech, Inc, South San Francisco, CA., Harvey C; Pharmacy and Clinical Support, Dana-Farber Cancer Institute, Boston, MA., Leth D; Pharmacy and Clinical Support, Dana-Farber Cancer Institute, Boston, MA., Faggen M; Dana-Farber Brigham Cancer Center in Clinical Affiliation With South Shore Hospital, Weymouth, MA., Sinclair N; Dana-Farber Brigham Cancer Center-Foxborough and Milford, Foxborough, MA., Walsh J; Dana-Farber/New Hampshire Oncology-Hematology, Londonderry, NH., Tung N; Harvard Medical School, Boston, MA.; Beth Israel Deaconess Medical Center, Boston, MA., Sinclair S; Eastern Maine Medical Center, Brewer, ME., Lo S; Bennett Cancer Center, Stamford Health, Stamford, CT., Yardley D; Sarah Cannon Research Institute, Nashville, TN., Valero V; The University of Texas MD Anderson Cancer Center, Houston, TX., Meisel J; Winship Cancer Institute at Emory University, Atlanta, GA., Ballinger TJ; Indiana University School of Medicine, Indianapolis, IN., Adams S; Perlmutter Cancer Center, NYU Langone Health, New York, NY., Carey LA; Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC., Rauch JK; UNC Health, Garner, NC., Abramson VG; Vanderbilt University Medical Center, Nashville, TN., Williams NO; Ohio State University Wexner Medical Center, Columbus, OH., Chen WY; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Leone JP; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Schumer ST; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Tayob N; Harvard Medical School, Boston, MA.; Data Sciences, Dana-Farber Cancer Institute, Boston, MA., Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2024 Jul 19, pp. OP2400021. Date of Electronic Publication: 2024 Jul 19.
Autor:
Tarantino P; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Tayob N; Harvard Medical School, Boston, MA.; Division of Data Science, Dana-Farber Cancer Institute, Boston, MA., Villacampa G; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Oncology Data Science Vall d'Hebron Institute of Oncology, Barcelona, Spain., Dang C; Memorial Sloan Kettering Cancer Center, New York, NY., Yardley DA; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN., Isakoff SJ; Harvard Medical School, Boston, MA.; Massachusetts General Hospital, Boston, MA., Valero V; MD Anderson Cancer Center, Houston, TX., Faggen M; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Mulvey T; Harvard Medical School, Boston, MA.; Massachusetts General Hospital, Boston, MA., Bose R; Washington University School of Medicine, St Louis, MO., Weckstein D; New Hampshire Oncology Hematology, Manchester, NH., Wolff AC; Johns Hopkins Sidney Kimmel Cancer Center, Washington, DC., Reeder-Hayes K; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Rugo HS; University of California, San Francisco, CA., Ramaswamy B; Ohio State University Comprehensive Cancer Center, Columbus, OH., Zuckerman D; St Luke's Mountain States Tumor Institute, Boise, ID., Hart L; Wake Forest Baptist Health, Winston-Salem, NC., Gadi VK; University of Illinois Cancer Center, Chicago, IL., Constantine M; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Cheng K; North Shore-LIJ Cancer Institute, Lake Success, NY., Garrett AM; Northern Light Cancer Care, Brewer, ME., Marcom PK; Duke University School of Medicine, Durham, NC., Albain K; Loyola University Medical Center, Maywood, IL., DeFusco P; Hartford Healthcare Cancer Institute, Hartford, CT., Tung N; Harvard Medical School, Boston, MA.; Beth Israel Deaconess Medical Center, Boston, MA., Ardman B; Lowell General Hospital, Lowell, MA., Nanda R; UChicago Medicine, Chicago, IL., Jankowitz RC; Perelman Center for Advanced Medicine, Philadelphia, PA., Rimawi M; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX., Abramson V; Vanderbilt-Ingram Cancer Center, Nashville, TN., Pohlmann PR; MD Anderson Cancer Center, Houston, TX.; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC., Van Poznak C; Rogel Cancer Center, University of Michigan, Ann Arbor, MI., Forero-Torres A; Kirklin UAB Hematology Oncology, Birmingham, AL., Liu MC; Natera, Inc, Austin, TX., Ruddy KJ; Mayo Clinic, Rochester, NY., Waks AG; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., DeMeo M; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA., Burstein HJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Partridge AH; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Dell'Orto P; IEO European Institute of Oncology, IRCCS, Milan, Italy., Russo L; IEO European Institute of Oncology, IRCCS, Milan, Italy., Krause E; PathAI, Boston, MA., Newhouse DJ; NanoString Technologies, Inc, Boston, MA., Kurt BB; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA., Mittendorf EA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA., Schneider B; Indiana University School of Medicine, Indianapolis, IN., Prat A; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Winer EP; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Yale Cancer Center, New Haven, CT., Krop IE; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Yale Cancer Center, New Haven, CT., Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jun 27, pp. JCO2302170. Date of Electronic Publication: 2024 Jun 27.
Autor:
Tarantino P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy., Leone J; Grupo Oncológico Cooperativo del Sur, Neuquén, Argentina., Vallejo CT; Grupo Oncológico Cooperativo del Sur, Neuquén, Argentina., Freedman RA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Waks AG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Martínez-Sáez O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Medical Oncology Department, Hospital Clinic of Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Garrido-Castro A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Lynce F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Tayob N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Lin NU; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Leone JP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. JoseP_Leone@dfci.harvard.edu.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA. JoseP_Leone@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. JoseP_Leone@dfci.harvard.edu.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2024 Apr 04; Vol. 10 (1), pp. 26. Date of Electronic Publication: 2024 Apr 04.
Autor:
Marín-Aguilera M; Scientific Department, Reveal Genomics, S.L., Barcelona, Spain., Jares P; Pathology Department, Hospital Clínic of Barcelona, Barcelona, Spain; Molecular Biology Core, Hospital Clínic Barcelona, Barcelona, Spain., Sanfeliu E; Pathology Department, Hospital Clínic of Barcelona, Barcelona, Spain., Villacampa G; SOLTI Breast Cancer Research Group, Barcelona, Spain; Statistical Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Hernández-Lllán E; Molecular Biology Core, Hospital Clínic Barcelona, Barcelona, Spain., Martínez-Puchol AI; Molecular Biology Core, Hospital Clínic Barcelona, Barcelona, Spain., Shankar S; Department of Pathology, Center for Advanced Medical Diagnostics, Brigham and Women's Hospital, Boston, USA., González-Farré B; Pathology Department, Hospital Clínic of Barcelona, Barcelona, Spain., Waks AG; Department of Pathology, Center for Advanced Medical Diagnostics, Brigham and Women's Hospital, Boston, USA., Brasó-Maristany F; Scientific Department, Reveal Genomics, S.L., Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain., Pardo F; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain., Manning DK; Department of Pathology, Center for Advanced Medical Diagnostics, Brigham and Women's Hospital, Boston, USA., Abery JA; Eremid Genomic Services, LLC, Kannapolis, USA., Curaba J; Eremid Genomic Services, LLC, Kannapolis, USA., Moon L; Eremid Genomic Services, LLC, Kannapolis, USA., Gordon O; Eremid Genomic Services, LLC, Kannapolis, USA., Galván P; Scientific Department, Reveal Genomics, S.L., Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain., Wachirakantapong P; Department of Pathology, Center for Advanced Medical Diagnostics, Brigham and Women's Hospital, Boston, USA., Castillo O; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain., Nee CM; Department of Pathology, Center for Advanced Medical Diagnostics, Brigham and Women's Hospital, Boston, USA., Blasco P; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain., Senevirathne TH; Department of Pathology, Center for Advanced Medical Diagnostics, Brigham and Women's Hospital, Boston, USA., Sirenko V; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain., Martínez-Sáez O; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain; Medical Oncology Department, Hospital Clinic Barcelona, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain., Aguirre A; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain., Krop IE; Yale Cancer Center, New Haven, USA., Li Z; Dana-Farber Cancer Institute, Boston, USA; Harvard Medical School, Boston, USA., Spellman P; Oregon Health and Science University, Portland, USA., Metzger Filho O; Department of Pathology, Center for Advanced Medical Diagnostics, Brigham and Women's Hospital, Boston, USA; Harvard Medical School, Boston, USA., Polyak K; Dana-Farber Cancer Institute, Boston, USA; Harvard Medical School, Boston, USA., Michaels P; Department of Pathology, Center for Advanced Medical Diagnostics, Brigham and Women's Hospital, Boston, USA., Puig-Butillé JA; Molecular Biology Core, Hospital Clínic Barcelona, Barcelona, Spain., Vivancos A; Cancer Genomics Core, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Matito J; Scientific Department, Reveal Genomics, S.L., Barcelona, Spain; Cancer Genomics Core, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Buckingham W; Scientific Department, Reveal Genomics, S.L., Barcelona, Spain., Perou CM; Department of Genetics, Lineberger Comprehensive Cancer Center, Chapel Hill, USA., Villagrasa-González P; Scientific Department, Reveal Genomics, S.L., Barcelona, Spain., Prat A; Scientific Department, Reveal Genomics, S.L., Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain; Medical Oncology Department, Hospital Clinic Barcelona, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain; Breast Cancer Unit, IOB-Quirón Salud, Barcelona, Spain., Parker JS; Department of Genetics, Lineberger Comprehensive Cancer Center, Chapel Hill, USA., Paré L; Scientific Department, Reveal Genomics, S.L., Barcelona, Spain. Electronic address: lpare@reveal-genomics.com.
Publikováno v:
ESMO open [ESMO Open] 2024 Mar; Vol. 9 (3), pp. 102903. Date of Electronic Publication: 2024 Mar 06.
Autor:
Weiss A; From the Division of Surgical Oncology, Department of Surgery, University of Rochester, Rochester, NY (Weiss)., Jin Q; Department of Data Science (Jin, Tayob), Dana-Farber Cancer Institute Boston, MA., Waks AG; Division of Medical Oncology (Waks, Metzger-Filho), Dana-Farber Cancer Institute Boston, MA.; Harvard Medical School, Boston, MA (Waks, Tayob, King, Metzger-Filho).; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA (Waks, Wrabel, King, Metzger-Filho)., Yardley D; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN (Yardley)., Spring LM; Massachusetts General Hospital, Boston, MA (Spring)., Wrabel E; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA (Waks, Wrabel, King, Metzger-Filho)., Tayob N; Department of Data Science (Jin, Tayob), Dana-Farber Cancer Institute Boston, MA.; Harvard Medical School, Boston, MA (Waks, Tayob, King, Metzger-Filho)., Viale G; Division of Pathology, European Institute of Oncology, IRCCS and University of Milan, Milan, Italy (Viale)., Krop IE; Yale Cancer Center, New Haven, CT (Krop)., King TA; Harvard Medical School, Boston, MA (Waks, Tayob, King, Metzger-Filho).; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA (Waks, Wrabel, King, Metzger-Filho).; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA (King)., Metzger-Filho O; Division of Medical Oncology (Waks, Metzger-Filho), Dana-Farber Cancer Institute Boston, MA.; Harvard Medical School, Boston, MA (Waks, Tayob, King, Metzger-Filho).; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA (Waks, Wrabel, King, Metzger-Filho).
Publikováno v:
Journal of the American College of Surgeons [J Am Coll Surg] 2024 Mar 01; Vol. 238 (3), pp. 303-311. Date of Electronic Publication: 2023 Dec 04.
Autor:
Li Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Metzger Filho O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Viale G; Division of Pathology, European Institute of Oncology, IRCCS, Milan, Italy.; University of Milan, School of Medicine, Milan, Italy., dell'Orto P; Division of Pathology, European Institute of Oncology, IRCCS, Milan, Italy., Russo L; Division of Pathology, European Institute of Oncology, IRCCS, Milan, Italy., Goyette MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Kamat A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard University, Cambridge, Massachusetts, USA., Yardley DA; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, Tennessee, USA., Gupta Abramson V; Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA., Arteaga CL; University of Texas Southwestern, Simmons Comprehensive Cancer Center, Dallas, Texas, USA., Spring LM; Department of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA., Chiotti K; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, Oregon, USA., Halsey C; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, Oregon, USA., Waks AG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., King TA; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Lester SC; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Bellon JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Winer EP; Department of Internal Medicine, Yale Cancer Center, New Haven, Connecticut, USA., Spellman PT; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, Oregon, USA., Krop IE; Department of Internal Medicine, Yale Cancer Center, New Haven, Connecticut, USA., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2024 Feb 01; Vol. 134 (7). Date of Electronic Publication: 2024 Feb 01.
Autor:
Villacampa G; SOLTI Breast Cancer Research Group, Barcelona; Oncology Data Science, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Tung NM; Beth Israel, Boston, USA., Pernas S; Medical Oncology Department, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona., Paré L; Reveal Genomics, Barcelona., Bueno-Muiño C; Medical Oncology Department, Hospital Infanta Cristina (Parla), Fundación de Investigación Biomédica del H.U. Puerta de Hierro, Majadahonda, Madrid., Echavarría I; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CiberOnc, Madrid., López-Tarruella S; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CiberOnc, Madrid., Roche-Molina M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CiberOnc, Madrid., Del Monte-Millán M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CiberOnc, Madrid., Marín-Aguilera M; Reveal Genomics, Barcelona., Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Waks AG; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston, USA., Pascual T; SOLTI Breast Cancer Research Group, Barcelona; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Martínez-Sáez O; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Vivancos A; Cancer Genomics Group, VHIO, Barcelona, Spain., Conte PF; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova; Istituto Oncologico Veneto, IRCCS, Padova, Italy., Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova; Istituto Oncologico Veneto, IRCCS, Padova, Italy., Vittoria Dieci M; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova; Istituto Oncologico Veneto, IRCCS, Padova, Italy., Griguolo G; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova; Istituto Oncologico Veneto, IRCCS, Padova, Italy., Cortés J; International Breast Cancer Center, Pangaea Oncology, Quirónsalud Group, Barcelona., Llombart-Cussac A; Arnau de Vilanova Hospital, Universidad Católica de Valencia, Valencia, Spain., Muñoz M; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Vidal M; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Adamo B; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Wolff AC; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore., DeMichele A; Department of Oncology, University of Pennsylvania, Philadelphia., Villagrasa P; Reveal Genomics, Barcelona., Parker JS; Lineberger Comprehensive Cancer Center, Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill., Perou CM; Lineberger Comprehensive Cancer Center, Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill., Fernandez-Martinez A; Lineberger Comprehensive Cancer Center, Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill., Carey LA; Lineberger Comprehensive Cancer Center, Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill., Mittendorf EA; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Harvard Medical School, Boston, USA; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, USA., Martín M; Department of Medical Oncology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CiberOnc, Madrid., Prat A; Reveal Genomics, Barcelona; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain; Institute of Oncology (IOB)-Quirón, Barcelona, Spain. Electronic address: alprat@clinic.cat., Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston; Institute of Oncology (IOB)-Quirón, Barcelona, Spain. Electronic address: sara_tolaney@dfci.harvard.edu.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Sep; Vol. 34 (9), pp. 783-795. Date of Electronic Publication: 2023 Jun 09.
Autor:
Weiss A; From the Harvard Medical School, Boston MA (Weiss, Li, Desai, Tung, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, Chikarmane, Tayob, Fing, Tolaney, Winer, Mittendorf, Waks).; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston MA (Weiss, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, DeMeo, Wrabel, Alberti, Chikarmane, King, Tolaney, Winer, Mittendorf, Waks).; Division of Breast Surgery, Department of Surgery (Weiss, Nakhlis, Dominici, King, Mittendorf)., Li T; From the Harvard Medical School, Boston MA (Weiss, Li, Desai, Tung, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, Chikarmane, Tayob, Fing, Tolaney, Winer, Mittendorf, Waks).; Department of Data Science (Li, Tayob)., Desai NV; From the Harvard Medical School, Boston MA (Weiss, Li, Desai, Tung, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, Chikarmane, Tayob, Fing, Tolaney, Winer, Mittendorf, Waks).; Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston MA (Desai, Tung)., Tung NM; From the Harvard Medical School, Boston MA (Weiss, Li, Desai, Tung, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, Chikarmane, Tayob, Fing, Tolaney, Winer, Mittendorf, Waks).; Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston MA (Desai, Tung)., Poorvu PD; From the Harvard Medical School, Boston MA (Weiss, Li, Desai, Tung, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, Chikarmane, Tayob, Fing, Tolaney, Winer, Mittendorf, Waks).; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston MA (Weiss, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, DeMeo, Wrabel, Alberti, Chikarmane, King, Tolaney, Winer, Mittendorf, Waks).; Department of Medical Oncology (Poorvu, Partridge, Sinclair, Faggen, Constantine, Krop, Tolaney, Winer, Waks) Dana-Farber Cancer Institute, Boston MA., Partridge AH; From the Harvard Medical School, Boston MA (Weiss, Li, Desai, Tung, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, Chikarmane, Tayob, Fing, Tolaney, Winer, Mittendorf, Waks).; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston MA (Weiss, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, DeMeo, Wrabel, Alberti, Chikarmane, King, Tolaney, Winer, Mittendorf, Waks).; Department of Medical Oncology (Poorvu, Partridge, Sinclair, Faggen, Constantine, Krop, Tolaney, Winer, Waks) Dana-Farber Cancer Institute, Boston MA., Nakhlis F; From the Harvard Medical School, Boston MA (Weiss, Li, Desai, Tung, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, Chikarmane, Tayob, Fing, Tolaney, Winer, Mittendorf, Waks).; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston MA (Weiss, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, DeMeo, Wrabel, Alberti, Chikarmane, King, Tolaney, Winer, Mittendorf, Waks).; Division of Breast Surgery, Department of Surgery (Weiss, Nakhlis, Dominici, King, Mittendorf)., Dominici L; From the Harvard Medical School, Boston MA (Weiss, Li, Desai, Tung, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, Chikarmane, Tayob, Fing, Tolaney, Winer, Mittendorf, Waks).; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston MA (Weiss, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, DeMeo, Wrabel, Alberti, Chikarmane, King, Tolaney, Winer, Mittendorf, Waks).; Division of Breast Surgery, Department of Surgery (Weiss, Nakhlis, Dominici, King, Mittendorf)., Sinclair N; From the Harvard Medical School, Boston MA (Weiss, Li, Desai, Tung, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, Chikarmane, Tayob, Fing, Tolaney, Winer, Mittendorf, Waks).; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston MA (Weiss, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, DeMeo, Wrabel, Alberti, Chikarmane, King, Tolaney, Winer, Mittendorf, Waks).; Department of Medical Oncology (Poorvu, Partridge, Sinclair, Faggen, Constantine, Krop, Tolaney, Winer, Waks) Dana-Farber Cancer Institute, Boston MA., Spring LM; From the Harvard Medical School, Boston MA (Weiss, Li, Desai, Tung, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, Chikarmane, Tayob, Fing, Tolaney, Winer, Mittendorf, Waks).; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston MA (Weiss, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, DeMeo, Wrabel, Alberti, Chikarmane, King, Tolaney, Winer, Mittendorf, Waks).; Division of Hematology-Oncology, Massachusetts General Hospital, Boston MA (Spring)., Faggen M; From the Harvard Medical School, Boston MA (Weiss, Li, Desai, Tung, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, Chikarmane, Tayob, Fing, Tolaney, Winer, Mittendorf, Waks).; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston MA (Weiss, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, DeMeo, Wrabel, Alberti, Chikarmane, King, Tolaney, Winer, Mittendorf, Waks).; Department of Medical Oncology (Poorvu, Partridge, Sinclair, Faggen, Constantine, Krop, Tolaney, Winer, Waks) Dana-Farber Cancer Institute, Boston MA., Constantine M; From the Harvard Medical School, Boston MA (Weiss, Li, Desai, Tung, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, Chikarmane, Tayob, Fing, Tolaney, Winer, Mittendorf, Waks).; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston MA (Weiss, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, DeMeo, Wrabel, Alberti, Chikarmane, King, Tolaney, Winer, Mittendorf, Waks).; Department of Medical Oncology (Poorvu, Partridge, Sinclair, Faggen, Constantine, Krop, Tolaney, Winer, Waks) Dana-Farber Cancer Institute, Boston MA., Krop IE; From the Harvard Medical School, Boston MA (Weiss, Li, Desai, Tung, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, Chikarmane, Tayob, Fing, Tolaney, Winer, Mittendorf, Waks).; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston MA (Weiss, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, DeMeo, Wrabel, Alberti, Chikarmane, King, Tolaney, Winer, Mittendorf, Waks).; Department of Medical Oncology (Poorvu, Partridge, Sinclair, Faggen, Constantine, Krop, Tolaney, Winer, Waks) Dana-Farber Cancer Institute, Boston MA., DeMeo M; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston MA (Weiss, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, DeMeo, Wrabel, Alberti, Chikarmane, King, Tolaney, Winer, Mittendorf, Waks)., Wrabel E; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston MA (Weiss, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, DeMeo, Wrabel, Alberti, Chikarmane, King, Tolaney, Winer, Mittendorf, Waks)., Alberti J; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston MA (Weiss, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, DeMeo, Wrabel, Alberti, Chikarmane, King, Tolaney, Winer, Mittendorf, Waks)., Chikarmane S; From the Harvard Medical School, Boston MA (Weiss, Li, Desai, Tung, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, Chikarmane, Tayob, Fing, Tolaney, Winer, Mittendorf, Waks).; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston MA (Weiss, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, DeMeo, Wrabel, Alberti, Chikarmane, King, Tolaney, Winer, Mittendorf, Waks).; Department of Radiology (Chikarmane), Brigham and Women's Hospital, Boston MA., Tayob N; From the Harvard Medical School, Boston MA (Weiss, Li, Desai, Tung, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, Chikarmane, Tayob, Fing, Tolaney, Winer, Mittendorf, Waks).; Department of Data Science (Li, Tayob)., King TA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston MA (Weiss, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, DeMeo, Wrabel, Alberti, Chikarmane, King, Tolaney, Winer, Mittendorf, Waks).; Division of Breast Surgery, Department of Surgery (Weiss, Nakhlis, Dominici, King, Mittendorf)., Tolaney SM; From the Harvard Medical School, Boston MA (Weiss, Li, Desai, Tung, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, Chikarmane, Tayob, Fing, Tolaney, Winer, Mittendorf, Waks).; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston MA (Weiss, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, DeMeo, Wrabel, Alberti, Chikarmane, King, Tolaney, Winer, Mittendorf, Waks).; Department of Medical Oncology (Poorvu, Partridge, Sinclair, Faggen, Constantine, Krop, Tolaney, Winer, Waks) Dana-Farber Cancer Institute, Boston MA., Winer EP; From the Harvard Medical School, Boston MA (Weiss, Li, Desai, Tung, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, Chikarmane, Tayob, Fing, Tolaney, Winer, Mittendorf, Waks).; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston MA (Weiss, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, DeMeo, Wrabel, Alberti, Chikarmane, King, Tolaney, Winer, Mittendorf, Waks).; Department of Medical Oncology (Poorvu, Partridge, Sinclair, Faggen, Constantine, Krop, Tolaney, Winer, Waks) Dana-Farber Cancer Institute, Boston MA., Mittendorf EA; From the Harvard Medical School, Boston MA (Weiss, Li, Desai, Tung, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, Chikarmane, Tayob, Fing, Tolaney, Winer, Mittendorf, Waks).; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston MA (Weiss, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, DeMeo, Wrabel, Alberti, Chikarmane, King, Tolaney, Winer, Mittendorf, Waks).; Division of Breast Surgery, Department of Surgery (Weiss, Nakhlis, Dominici, King, Mittendorf)., Waks AG; From the Harvard Medical School, Boston MA (Weiss, Li, Desai, Tung, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, Chikarmane, Tayob, Fing, Tolaney, Winer, Mittendorf, Waks).; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston MA (Weiss, Poorvu, Partridge, Nakhlis, Dominici, Sinclair, Spring, Faggen, Constantine, Krop, DeMeo, Wrabel, Alberti, Chikarmane, King, Tolaney, Winer, Mittendorf, Waks).; Department of Medical Oncology (Poorvu, Partridge, Sinclair, Faggen, Constantine, Krop, Tolaney, Winer, Waks) Dana-Farber Cancer Institute, Boston MA.
Publikováno v:
Journal of the American College of Surgeons [J Am Coll Surg] 2023 Aug 01; Vol. 237 (2), pp. 247-256. Date of Electronic Publication: 2023 May 17.